Zimmer Biomet Holdings EMEA — Selling General And Administrative Expense increased by 3.2% to $149.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.2%, from $123.30M to $149.50M. Over 3 years (FY 2022 to FY 2025), EMEA — Selling General And Administrative Expense shows an upward trend with a 3.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Rising expenses relative to revenue may indicate increased investment in market growth or potential inefficiencies in regional operations.
Operating expenses incurred to support the sales, marketing, and administrative functions of the EMEA segment. This incl...
Used to benchmark regional operating leverage against industry peers.
zbh_segment_emea_selling_general_and_administrative_expense| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $120.80M | $120.80M | $120.80M | $120.80M | $124.70M | $124.70M | $124.70M | $124.70M | $133.20M | $128.00M | $117.60M | $120.10M | $123.30M | $136.60M | $132.40M | $144.80M | $149.50M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +3.2% | +0.0% | +0.0% | +0.0% | +6.8% | -3.9% | -8.1% | +2.1% | +2.7% | +10.8% | -3.1% | +9.4% | +3.2% |
| YoY Change | — | — | — | — | +3.2% | +3.2% | +3.2% | +3.2% | +6.8% | +2.6% | -5.7% | -3.7% | -7.4% | +6.7% | +12.6% | +20.6% | +21.2% |